Ocular Therapeutix Inc

Abierto

SectorSanidad

9.83 1.03

Resumen

Variación precio

24h

Actual

Mínimo

9.63

Máximo

10.08

Métricas clave

By Trading Economics

Ingresos

-24M

-89M

Ventas

-2.5M

11M

BPA

-0.4

Margen de beneficios

-821.623

Empleados

325

EBITDA

-24M

-85M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+156.35% upside

Dividendos

By Acuity

Próximas Ganancias

4 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

44M

2.2B

Apertura anterior

8.8

Cierre anterior

9.83

Noticias sobre sentimiento de mercado

By Acuity

58%

42%

277 / 342 Clasificación en Healthcare

Ocular Therapeutix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

25 jun 2026, 23:51 UTC

News

Crude oil prices rise amid escalating Middle East tensions after a projectile strike near Oman. The United States Oil Fund LP is slightly higher after hours.

25 jun 2026, 23:51 UTC

Social Media
Correlated Moves
News

Qualcomm is in talks to acquire Modular for $4 billion. Shares are trading lower after the company's optimistic revenue targets and Investor Day updates.

25 jun 2026, 23:51 UTC

Social Media
News

Micron Technology Inc. shares fell in after-market trading despite a 350% year-over-year revenue increase, amid broader tech sector weakness.

25 jun 2026, 23:42 UTC

News
Macro News
ETF Constituents

The Vanguard Information Technology ETF rose in after-market trading, boosted by Micron's strong earnings and revenue forecast, despite mixed broader market sentiment.

25 jun 2026, 23:41 UTC

ETF Constituents
Social Media
News
Correlated Moves

SPDR S&P 500 ETF Trust trades higher after market close, supported by positive returns from top holdings like Microsoft and Apple amid mixed market sentiment.

25 jun 2026, 23:41 UTC

News
ETF Constituents
Social Media

Invesco QQQ Trust Series I rises in after-market hours, supported by a gain in the Nasdaq 100. Microsoft, Apple, and Meta contributed positively to performance.

25 jun 2026, 23:41 UTC

News
Social Media

Apple Inc. has raised prices for its MacBook and iPad models due to higher memory and storage costs. Shares are advancing in after-market trading.

25 jun 2026, 23:41 UTC

Social Media
News

Microsoft shares are higher in after-market trading following Thursday's close. Analysts are cautious amid rising console storage costs and AI spending concerns.

25 jun 2026, 23:26 UTC

News
ETF Constituents
Social Media

Vanguard Growth ETF shares advanced in after-market trading, supported by gains from Microsoft, Apple, and Meta, following four sessions of declines.

25 jun 2026, 23:22 UTC

News

Tesla's energy division may drive growth amid EV market challenges. Shares traded roughly flat during after-market hours following Thursday's close.

25 jun 2026, 23:06 UTC

ETF Constituents
News

The SPDR Dow Jones Industrial Average ETF Trust is higher in after-market trading, supported by positive economic data and contributions from Microsoft and Goldman Sachs.

25 jun 2026, 20:07 UTC

News
Macro Event
Correlated Moves

The USD/SEK exchange rate is lower today, influenced by upward revisions in US GDP growth and personal spending figures.

25 jun 2026, 20:07 UTC

News

Starbucks shares are lower despite reports of U.S. sales growth and upgraded earnings guidance. The stock pulled back from earlier session highs amid broader market dynamics.

25 jun 2026, 20:07 UTC

Macro Event
News

Positive U.S. macroeconomic indicators lift USD/NOK, which is trading higher since Wednesday's close and remains near the upper end of its one-month range.

25 jun 2026, 20:07 UTC

Macro Event
News

The USD/CZK exchange rate remains roughly flat, influenced by recent U.S. economic reports, including an upward revision of Q1 GDP growth to 2.1%.

25 jun 2026, 20:07 UTC

Correlated Moves
News
Macro Event

The USD/PLN is trading lower today, influenced by recent U.S. economic data and a slight decline in the US Dollar Index.

25 jun 2026, 20:07 UTC

News
Macro Event
Correlated Moves

The USD/HUF exchange rate is lower today, reflecting a slight decline since Wednesday. U.S. macroeconomic data contributed to recent volatility in the currency pair.

25 jun 2026, 20:07 UTC

Correlated Moves
Macro Event
News

The USD/DKK exchange rate is declining, influenced by upward revisions in US GDP growth and muted responses to personal income and spending data.

25 jun 2026, 20:07 UTC

News
Correlated Moves

The GBP/HKD exchange rate is rising, supported by an increase in GBP/USD amid ongoing inflation concerns and geopolitical tensions in the Strait of Hormuz.

25 jun 2026, 20:07 UTC

News
Correlated Moves

Ethereum is lower today, influenced by Bitcoin's decline. It remains below its 20-day moving average and has finished lower for three consecutive sessions.

25 jun 2026, 20:07 UTC

Correlated Moves
Macro Event
News

Bitcoin is lower today, impacted by the expiration of $10 billion in options and geopolitical tensions. Ethereum also declines, reflecting similar market conditions.

25 jun 2026, 20:07 UTC

Macro Event
News
Correlated Moves

Bitcoin is lower today, driven by the expiration of $10 billion in options and geopolitical tensions following an attack in the Strait of Hormuz.

25 jun 2026, 20:06 UTC

News

The Nikkei 225 Index is higher in after-market hours, supported by earlier gains and remaining above its 20-day moving average. No specific news was identified.

25 jun 2026, 19:56 UTC

ETF Constituents
News
Correlated Moves

Vanguard Real Estate ETF is higher as Simon Property Group and Welltower contribute positively, despite uncertainty from the postponed housing affordability bill.

25 jun 2026, 19:56 UTC

News
Macro Event
Social Media

Geopolitical tensions from an attack on a cargo ship have pressured U.S. Treasury yields, contributing to a decline in the iShares 20+ Year Treasury Bond ETF.

25 jun 2026, 19:46 UTC

Correlated Moves
News

Ethereum is trading lower amid persistent inflation and geopolitical tensions affecting oil supply. The asset remains below its 20-day moving average.

25 jun 2026, 19:26 UTC

News

Sirius XM Holdings Inc. is lower amid mixed US market performance and declines in major tech stocks, reflecting profit-taking and valuation concerns.

25 jun 2026, 19:16 UTC

Correlated Moves
News

The U.S. core PCE price index rose in May, suggesting ongoing inflation. The Vanguard Mortgage-Backed Securities ETF is trading higher since Wednesday's close.

25 jun 2026, 19:16 UTC

Macro Event
Correlated Moves
News

The Vanguard Total Bond Market ETF is higher today, supported by rising inflation data and an upward revision in Q1 GDP growth, reflecting stronger economic activity.

24 jun 2026, 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

Comparación entre iguales

Cambio de precio

Ocular Therapeutix Inc previsión

Precio Objetivo

By TipRanks

156.35% repunte

Estimación a 12 Meses

Media 25.25 USD  156.35%

Máximo 31 USD

Mínimo 18 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocular Therapeutix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

9

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

277 / 342 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Ocular Therapeutix Inc

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is developing AXPAXLI, an axitinib intravitreal implant that is in phase 3 trials for the treatment of wet age-related macular degeneration and other retinal diseases; PAXTRAVA, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company offers modulator for intermediate and late dry age-related macular degeneration; and gene delivery for inherited retinal degenerations and protein biofactory indications. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.